GDF15 and metabolic dysfunction-associated steatotic liver disease: Defining the GDF-15–immune cell–NAFLD axis could deepen our understanding of NAFLD pathogenesis and provide robust evidence for developing feasible screening and prevention strategies for NAFLD.